When most people think about Alzheimer's prevention research, they picture drug trials. And drug trials are indeed central to the field. But some of the most compelling evidence for reducing Alzheimer's risk doesn't come from a pill — it comes from decisions made every day.
This isn't a reason to abandon hope in pharmaceutical prevention. It's a reason to understand the full picture of what the science currently supports.
The Lancet Commission's 12 Risk Factors
In 2020, The Lancet Commission on Dementia Prevention, Intervention and Care identified 12 modifiable risk factors that, if addressed, could theoretically prevent or delay up to 40% of dementia cases worldwide. These include:
None of these are genetic. All of them are, to varying degrees, addressable.
Sleep: The Underrated Factor
One factor not yet included in the Lancet model — but growing rapidly in research prominence — is sleep. During deep sleep, the brain's glymphatic system clears metabolic waste products, including amyloid-beta, the protein that accumulates in the brains of Alzheimer's patients.
Studies have found that people who consistently sleep fewer than six hours per night in midlife have a higher risk of developing dementia later on. While the causal relationship is still being investigated, the biological plausibility is strong enough that sleep quality has become a serious area of focus in prevention research.
Cardiovascular Health and the Brain
What is good for your heart is increasingly understood to be good for your brain. High blood pressure, diabetes, and high cholesterol in midlife are all associated with elevated dementia risk. The mechanisms are multiple — from reduced blood flow to increased inflammation — and they operate over decades.
The FINGER trial, a landmark Finnish prevention study, demonstrated that a multimodal intervention targeting diet, exercise, cognitive training, and vascular risk management significantly improved cognitive performance in at-risk older adults. It is now the basis for a global network of similar trials.
What This Means for You
The science of Alzheimer's prevention is not waiting for a single breakthrough drug. It is advancing on multiple fronts simultaneously — genetic research, biomarker development, pharmaceutical trials, and lifestyle intervention studies are all part of the same effort.
For individuals, this means that prevention is not passive. There are evidence-informed steps that can be taken today to support long-term brain health — and clinical research that can be participated in to advance the science for everyone.
Tommorrow Study Collective will continue to translate this research as it develops, with the rigor it deserves and the accessibility everyone needs.
